Insulin-like growth factor (IGF) signaling greatly impacts the development and growth of the
central nervous system (CNS). IGF-I and IGF-II, two ligands of the IGF system, exert a wide …

Leptin, a peptide hormone secreted by adipocytes, plays a central role in controlling appetite
and weight in both rodents and humans. Basic science and clinical research suggest that …

Objective: To evaluate the effects of 20 weeks of resistance and concurrent training on
psychotic and depressive symptoms, quality of life outcomes, and serum IGF-1, IGFBP-3 …

Metabolic syndrome is associated with both schizophrenia and antipsychotic medication,
especially clozapine, with alterations in inflammatory cytokines and adipokines. However …

Objective In the current study, we aimed to investigate fasting plasma levels of glucose,
insulin, growth hormone, IGF-1, and lipid profile in remission schizophrenia patients …

Elevated blood levels of S100B in schizophrenia have so far been mainly attributed to glial
pathology, as S100B is produced by astro‐and oligodendroglial cells and is thought to act …

BACKGROUND: In recent years, several studies showed increased rates of hyperglycaemia,
diabetes, dyslipidemia, metabolic syndrome as well as cardiovascular disease in …

Given that foods and nutrients have been shown to influence the pharmacokinetics of drugs,
drugs may cause changes in the nutritional status of patients and their response to a given …

People with a mental illness show a growing incidence of obesity, and higher rates of
metabolic syndrome when compared with the general population. This paper reviews …

Background Numerous studies have implicated abnormal insulin-like growth factor 1 (IGF-1)
in the pathophysiology of schizophrenia, but findings have been inconsistent. Methods We …